Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) shares crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.01 and traded as low as $0.0071. Evofem Biosciences shares last traded at $0.0071, with a volume of 643,430 shares.
Evofem Biosciences Trading Up 6.8%
The firm has a market capitalization of $1.03 million, a PE ratio of -0.01 and a beta of -1.30. The stock’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Recommended Stories
- Five stocks we like better than Evofem Biosciences
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
